[ad_1] Isomorphic Labs, the London-based, drug discovery-focused spin-out of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants,...
[ad_1] Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for the roughly...
[ad_1] By Adria Calatayud Novartis raised its full-year earnings guidance for the third time this year after it reported higher net profit and sales for the...
[ad_1] By Adria Calatayud Novartis said an interim analysis from a phase 3 trial to evaluate its investigational iptacopan drug in patients with kidney disease nephropathy...
[ad_1] By Adria Calatayud Novartis said the planned spinoff of its Sandoz generic pharmaceuticals and biosimilars business is expected to occur on or around Oct. 4....
[ad_1] We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. Summary Summary U.S Europe Asia FX Rates...